(Q43632009)

25 November 2017

title

Normal growth during lamotrigine monotherapy in pediatric epilepsy patients -- a prospective evaluation of 103 children and adolescents (English)

1 reference

25 November 2017

1 reference

1 reference

M A Ueberall

1

1 reference

25 November 2017

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

46

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

63-67

1 reference

Weight loss in patients taking felbamate.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

[The growth rate of healthy children in the first 16 years: Bonn-Dortmund longitudinal developmental study]

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Changes in body weight with chronic, high-dose gabapentin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Stable weight during lamotrigine therapy: a review of 32 studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Effects of sodium valproate in 100 children with special reference to weight

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Obesity and endocrine disorders in women taking valproate for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Topiramate--safety and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Managing pediatric epilepsy syndromes with new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900250-9

7 January 2021

10.1016/S0920-1211(01)00250-9

Identifiers

DOI

1 reference

25 November 2017

1 reference